Journal of medical case reports · 2025
Oral ulcers in hematological malignancy patients undergoing chemotherapy: is it chemotherapy or neutropenia?: a case report and review of the literature.
СтатьяКлинический случайОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Al Beesh Fatima AlZahraa, Martini Nafiza, Suleiman Siham, Aljoujou Abeer
Аннотация
BACKGROUND: Chemotherapy can cause oral complications either directly, by inducing mucosal degeneration, or indirectly, through myelosuppression leading to neutropenia. Neutropenia, a common side effect, is often associated with multiple oral ulcers.
CASE PRESENTATION: A 39-year-old Arabic Syrian man with acute myelogenous leukemia developed neutropenia following his initial chemotherapy course, resulting in oral ulcers. A complete blood count confirmed chemotherapy-induced neutropenia, and the clinical presentation supported the diagnosis of neutropenic ulcers. The patient's chemotherapy regimen was temporarily halted, and a topical corticosteroid paste containing triamcinolone acetonide was applied three times daily for 7 days. This treatment led to significant regression of the ulcers. The patient provided written informed consent after receiving a detailed explanation of the study's objectives, procedures, and privacy considerations.
CONCLUSION: Topical corticosteroid treatment effectively promoted significant regression of neutropenic ulcers in this case.
CASE PRESENTATION: A 39-year-old Arabic Syrian man with acute myelogenous leukemia developed neutropenia following his initial chemotherapy course, resulting in oral ulcers. A complete blood count confirmed chemotherapy-induced neutropenia, and the clinical presentation supported the diagnosis of neutropenic ulcers. The patient's chemotherapy regimen was temporarily halted, and a topical corticosteroid paste containing triamcinolone acetonide was applied three times daily for 7 days. This treatment led to significant regression of the ulcers. The patient provided written informed consent after receiving a detailed explanation of the study's objectives, procedures, and privacy considerations.
CONCLUSION: Topical corticosteroid treatment effectively promoted significant regression of neutropenic ulcers in this case.